The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksJPMorgan Japanese Regulatory News (JFJ)

Share Price Information for JPMorgan Japanese (JFJ)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 525.00
Bid: 522.00
Ask: 524.00
Change: 7.00 (1.35%)
Spread: 2.00 (0.383%)
Open: 508.00
High: 525.00
Low: 508.00
Prev. Close: 518.00
JFJ Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Private Placement of Yen Debt

2 Aug 2018 11:42

RNS Number : 6480W
JPMorgan Japanese Inv. Trust PLC
02 August 2018
 

LONDON STOCK EXCHANGE ANNOUNCEMENT

 

JPMORGAN JAPANESE INVESTMENT TRUST PLC

 

Legal Entity Identifier: 549300JZW3TSSO464R15

Information disclosed in accordance with Market Abuse Regulation Article 19

 

Private Placement of Yen Debt

 

The Board of the Company announces that it has completed the sale of Y13bn of Senior Secured Notes (the "Notes") at an average annualised interest rate of 1.10%.

 

The notes have been placed in five tranches:

(i) ¥2,000,000,000 in aggregate principal amount of its 0.76% Series A Senior Secured Notes due 2nd August 2028;

(ii) ¥2,500,000,000 in aggregate principal amount of its 0.95% Series B Senior Secured Notes due 2nd August 2033;

(iii) ¥2,500,000,000 in aggregate principal amount of its 1.11% Series C Senior Secured Notes due 2nd August 2038;

(iv) ¥2,500,000,000 in aggregate principal amount of its 1.21% Series D Senior Secured Notes due 2nd August 2043 and

(v) ¥3,500,000,000 in aggregate principal amount of its 1.33% Series E Senior

Secured Notes due 2nd August 2048.

 

The net proceeds from the sale of the Notes will be used to repay elements of the Company's current indebtedness, namely the ¥9,000,000,000 term loan and ¥4,000,000,000 of the ¥11,000,000,000 revolving credit facility. Both of these existing facilities are provided by National Australia Bank.

 

There has been no change in the Investment Managers' permitted gearing range, as previously set by the Board, to limit gearing within the range of 5% net cash to 20% geared in normal market conditions.

 

Andrew Fleming Chairman, commented:

 

"We are pleased to be able to take advantage of current market conditions which have offered the opportunity to secure long term debt financing at rates below that paid on the Company's existing term loan and in yen so there is no currency mismatch with the Company's underlying assets."

 

2nd August 2018

 

 

For further information:

 

Faith Pengelly

JPMorgan Funds Limited 020 7742 4000

 

Disclaimer

The Notes have not been and will not be registered under the U.S. Securities Act of 1933, as amended (the "Act") and may not be offered or sold in the United States absent registration or an applicable exemption from the registration requirements of the Act. This notice is for information only, does not constitute an offer to sell or the solicitation of an offer to buy any security and shall not constitute an offer, solicitation or sale of any securities in any jurisdiction in which such offer, solicitation or sale would be unlawful.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
MSCEAEPAEDNPEFF
Date   Source Headline
3rd Jan 20245:12 pmRNSTransaction in Own Shares
3rd Jan 202411:23 amRNSNet Asset Value(s)
2nd Jan 20241:54 pmRNSGearing Announcement
2nd Jan 20241:22 pmRNSNet Asset Value(s)
2nd Jan 202411:18 amRNSTotal Voting Rights
29th Dec 202311:24 amRNSNet Asset Value(s)
28th Dec 202311:28 amRNSNet Asset Value(s)
27th Dec 202312:42 pmRNSGearing Announcement
27th Dec 202311:54 amRNSNet Asset Value(s)
22nd Dec 202311:08 amRNSNet Asset Value(s)
21st Dec 20235:44 pmRNSTransaction in Own Shares - Replacement
21st Dec 20235:10 pmRNSTransaction in Own Shares
21st Dec 202310:45 amRNSNet Asset Value(s)
20th Dec 20235:01 pmRNSTransaction in Own Shares
20th Dec 20231:13 pmRNSHolding(s) in Company
20th Dec 202310:35 amRNSNet Asset Value(s)
19th Dec 202312:16 pmRNSHolding(s) in Company
19th Dec 202311:30 amRNSNet Asset Value(s)
18th Dec 20235:01 pmRNSTransaction in Own Shares
18th Dec 202311:18 amRNSGearing Announcement
18th Dec 202310:24 amRNSNet Asset Value(s)
15th Dec 20235:09 pmRNSTransaction in Own Shares
15th Dec 202311:19 amRNSNet Asset Value(s)
14th Dec 20235:05 pmRNSTransaction in Own Shares
14th Dec 202310:35 amRNSNet Asset Value(s)
13th Dec 20235:09 pmRNSTransaction in Own Shares
13th Dec 202310:35 amRNSNet Asset Value(s)
12th Dec 20236:17 pmRNSTen Largest Investments
12th Dec 20235:04 pmRNSTransaction in Own Shares
12th Dec 202310:34 amRNSNet Asset Value(s)
11th Dec 20235:01 pmRNSTransaction in Own Shares
11th Dec 202311:52 amRNSGearing Announcement
11th Dec 202310:37 amRNSNet Asset Value(s)
8th Dec 202310:35 amRNSNet Asset Value(s)
7th Dec 20235:09 pmRNSTransaction in Own Shares
7th Dec 202310:24 amRNSNet Asset Value(s)
6th Dec 202311:00 amRNSNet Asset Value(s)
6th Dec 20237:10 amRNSDividend Declaration
6th Dec 20237:00 amRNSAnnual Financial Report
5th Dec 202310:50 amRNSNet Asset Value(s)
4th Dec 20235:19 pmRNSTransaction in Own Shares
4th Dec 202312:35 pmRNSGearing Announcement
4th Dec 202311:13 amRNSNet Asset Value(s)
1st Dec 20235:01 pmRNSTransaction in Own Shares
1st Dec 202312:40 pmRNSHolding(s) in Company
1st Dec 202312:09 pmRNSTotal Voting Rights
1st Dec 202312:07 pmRNSNet Asset Value(s)
30th Nov 20235:15 pmRNSTransaction in Own Shares
30th Nov 202311:13 amRNSNet Asset Value(s)
29th Nov 202311:04 amRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.